Drug Name: Omvoh Active Ingredient: mirikizumab-mrkz Indication: To treat ulcerative colitis Approval Date: 10/26/2023 Company: Eli Lilly and Company More: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761279s000lbl.pdf
Drug Name: Zilbrysq Active Ingredient: zilucoplan Indication: To treat moderately to severely active ulcerative colitis in adults Approval Date: 10/17/2023 Company: UCB, Inc. More: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216834s000lbl.pdf
Drug Name: Velsipity Active Ingredient: etrasimod Indication: To treat moderately to severely active ulcerative colitis in adults Approval Date: 10/12/2023 Company: Pfizer Inc More: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-announces-fda-and-ema-acceptance-etrasimod